These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9134974)

  • 21. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
    Takashima H; Tsujihata M; Kishikawa M; Freed WJ
    Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity.
    Zou L; Jankovic J; Rowe DB; Xie W; Appel SH; Le W
    Life Sci; 1999; 64(15):1275-85. PubMed ID: 10227583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of rat inferior olivary neurons to 3-acetylpyridine.
    Anderson WA; Flumerfelt BA
    Brain Res; 1984 Feb; 314(2):285-91. PubMed ID: 6704754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pramipexole upregulates dopamine receptor D₂ and D₃ expression in rat striatum.
    Tokunaga N; Choudhury ME; Nishikawa N; Nagai M; Tujii T; Iwaki H; Kaneta M; Nomoto M
    J Pharmacol Sci; 2012; 120(2):133-7. PubMed ID: 22986363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective actions of peripherally administered insulin-like growth factor I in the injured olivo-cerebellar pathway.
    Fernandez AM; Gonzalez de la Vega AG; Planas B; Torres-Aleman I
    Eur J Neurosci; 1999 Jun; 11(6):2019-30. PubMed ID: 10336671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of 3-acetylpyridine on inferior olivary neuron degeneration in Lurcher mutant and wild-type mice.
    Caddy KW; Vozeh F
    Eur J Pharmacol; 1997 Jul; 330(2-3):139-42. PubMed ID: 9253946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease.
    Holtz NA; Tedford SE; Persons AL; Grasso SA; Napier TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():77-84. PubMed ID: 27216282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen.
    Wynalda MA; Wienkers LC
    Drug Metab Dispos; 1997 Oct; 25(10):1211-4. PubMed ID: 9321526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
    Iravani MM; Sadeghian M; Leung CC; Tel BC; Rose S; Schapira AH; Jenner P
    Exp Neurol; 2008 Aug; 212(2):522-31. PubMed ID: 18571649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-dependent susceptibility of inferior olive neurones to 3-acetylpyridine in the rat.
    Woodhams P; Rodd R; Balázs R
    Brain Res; 1978 Sep; 153(1):194-8. PubMed ID: 679046
    [No Abstract]   [Full Text] [Related]  

  • 31. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
    Siuciak JA; Fujiwara RA
    Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats.
    Lorenc-Koci E; Wolfarth S
    Eur J Pharmacol; 1999 Nov; 385(1):39-46. PubMed ID: 10594343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-treatment with riluzole, a neuroprotective drug, ameliorates the 3-acetylpyridine-induced neurotoxicity in cerebellar Purkinje neurones of rats: behavioural and electrophysiological evidence.
    Janahmadi M; Goudarzi I; Kaffashian MR; Behzadi G; Fathollahi Y; Hajizadeh S
    Neurotoxicology; 2009 May; 30(3):393-402. PubMed ID: 19442824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
    Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromocriptine prevents spinal motor neuron death following sciatic nerve transection in neonatal rats.
    Iwasaki Y; Shiojima T; Ikeda K; Kinoshita M
    Neurosci Lett; 1996 Aug; 214(2-3):139-42. PubMed ID: 8878103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. U-95666E: a potential anti-parkinsonian drug with anxiolytic activity.
    Sethy VH; Ellerbrock BR; Wu H
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):873-83. PubMed ID: 9278957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting necrotic neurons with fluoro-jade stain.
    Krinke GJ; Classen W; Vidotto N; Suter E; Würmlin CH
    Exp Toxicol Pathol; 2001 Oct; 53(5):365-72. PubMed ID: 11817106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
    Guttman M
    Neurology; 1997 Oct; 49(4):1060-5. PubMed ID: 9339690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of repeated treatment with pramipexole on the central dopamine D3 system.
    Maj J; Rogói Z; Margas W; Kata M; Dziedzicka-Wasylewska M
    J Neural Transm (Vienna); 2000; 107(12):1369-79. PubMed ID: 11458990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effects of pramipexole in young and aged MPTP-treated mice.
    Anderson DW; Neavin T; Smith JA; Schneider JS
    Brain Res; 2001 Jun; 905(1-2):44-53. PubMed ID: 11423078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.